Developing tools for precise delivery of molecules to study cellular responses
Spatially and Temporarily Resolved Precision Delivery for Quantitative Biological Studies
This study is working on new tools that help scientists send tiny molecules to specific cells so they can see how those cells react to different chemicals, which could help us learn more about how cells behave in health and illness.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-10927317 on NIH RePORTER |
What this research studies
This research focuses on creating advanced tools that can precisely deliver molecules to individual cells, allowing scientists to study how these cells respond to various chemical stimuli over time. By using a specialized nanopipette electrode, the team aims to control the delivery of important biological molecules, such as nitric oxide, in a way that captures the dynamic interactions within the cellular environment. This approach will enhance our understanding of cellular behavior and the role of reactive molecules in health and disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that involve cellular responses, such as cardiovascular diseases or inflammatory disorders.
Not a fit: Patients with stable conditions that do not involve significant cellular response variability may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in understanding cellular responses, potentially improving treatments for diseases related to cellular dysfunction.
How similar studies have performed: Other research has shown promise in using precision delivery techniques for studying cellular responses, indicating that this approach could yield valuable insights.
Where this research is happening
Austin, United States
- University of Texas at Austin — Austin, United States (Active)
Researchers
- Principal investigator: Ren, Hang — University of Texas at Austin
- Study coordinator: Ren, Hang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.